Introduction
Failure to control inflammatory macrophage activation responses can lead to pathological diseases, best exemplified by sepsis. Despite our growing understanding of its pathogenesis, sepsis continues to affect more than 200,000 people annually in the US with a mortality rate as high as 50% 1, 2 . The severe pathology associated with sepsis occurs in response to the hyper-production of macrophage-derived inflammatory cytokines, which can lead to vascular and tissue destruction, multiple organ failure, shock, and death 3 . Intriguingly though, macrophages isolated from late-stage septic individuals exhibit the phenotype of immunosuppressive, regulatory macrophages, expressing high levels of the antiinflammatory cytokine IL-10, and low levels of TNFα and IL-12 [4] [5] [6] . These observations suggest the transition from inflammatory to immunosuppressive macrophages may be critical to control initial inflammatory responses and prevent lethal septic shock 4, 7, 8 . However, the molecular mechanism by which this transition is achieved remains poorly understood.
In the present work, we examine the role that endogenous CD39 and ATP play in regulating the macrophage inflammatory response. Recently, extracellular ATP (eATP) has been characterized as a 'danger signal' that can promote inflammation through P2X7-dependent activation of the NLRP3 inflammasome leading to IL-1β production [9] [10] [11] [12] . Importantly, however, such results were shown to be dependent on the addition of millimolar levels of exogenous ATP in vitro. These high levels of eATP have yet to be discovered in vivo, and the concentration of eATP is carefully controlled by the ecto-nucleoside For personal use only. on July 15, 2017 . by guest www.bloodjournal.org From triphosphate diphosphohydralse (ENTPDase1/CD39) 13, 14 . It was recently shown macrophages express CD39, and that it played a role in modulating the P2X7-dependent production of IL-1β 15 in the presence of exogenously added ATP. Several issues remain incompletely understood regarding how ATP and CD39 contribute to the regulation of macrophage activation. First, the potential for macrophages to be an endogenous source of ATP has not been fully addressed. Unlike most cells, macrophages primarily generate ATP through glycolysis 16, 17 . Moreover, macrophages increase the rate of glycolysis in response to TLR stimulation 18 . Previous attempts to measure ATP release from macrophages have yielded inconsistent results [19] [20] [21] that were likely complicated by endogenous CD39 activity. Second, if macrophages are indeed a source of ATP, the mechanism by which they release ATP into the extracellular milieu has not been previously defined. Third, there is currently a paucity of studies investigating how ATP and CD39 influence inflammasome-independent responses, such as TNFα production 4, 8, 22 . Finally, the specific contribution of CD39 on macrophages in directing the course of inflammatory disease remains unknown.
In the present study, we demonstrate that in response to a variety of TLR ligands, macrophages synthesize, secrete, and hydrolyze ATP to control their own activation status. Surprisingly, the ATP that is generated does not stimulate IL-1β release but rather suppresses the production of pro-inflammatory cytokines like TNFα and IL-12. Mechanistically, we show that macrophages hydrolyze selfreleased ATP via CD39, to generate immunosuppressive adenosine. CD39-For personal use only. on July 15, 2017 . by guest www.bloodjournal.org From 6 mediated adenosine generation results in a dramatic reprogramming of the macrophage activation response, to enhance not only IL-10 production, but also many newly identified regulatory macrophage-specific transcripts [23] [24] [25] [26] . Finally, we demonstrate that macrophage-specific expression of CD39 is critical in preventing lethal hyper-inflammatory responses to LPS in vivo. Taken together, our data indicate that CD39 acts as a "molecular switch" that controls the balance between inflammatory and regulatory macrophage differentiation. For detailed experimental protocols, list of reagents, primer pairs, and antibody clones used in this study please refer to Supplemental Methods. , and the release of ATP was measured.
Results

TLR stimulation results in
The results revealed that ATP secreted by macrophages was strongly dependent on pannexin-1 ( Figure 1C ). The blockade of pannexin-1-mediated ATP release was also recapitulated when macrophages were stimulated with LPS in the presence of carbenoxolone (CBX), but not in the presence of flufenamic acid
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From (FFA), which preferentially inhibits pannexin and related connexin channels, respectively 35 ( Figure 1C ). Thus, these results suggest that pannexin-1 channels are indeed the major conduits from which ATP is released from TLRstimulated macrophages.
Surprisingly, very little eATP was detected from LPS-stimulated bone marrow-derived murine macrophages (BMDMs) relative to LPS-stimulated RAW264.7 cells ( Figure 1D ), despite similar expression levels of pannexin-1 both at the mRNA and the protein level ( Figure 1E and data not shown). We hypothesized that BMDMs may control the bioavailability of self-released eATP and express higher levels of CD39, thereby decreasing eATP detection. Indeed,
Cd39 transcript levels were below detection in RAW264.7 cells, but present in BMDMs ( Figure 1E ). CD39 expression on the surface of RAW264.7 cells was 10-fold less than on BMDMs ( Figure 1F ). We further evaluated whether culture conditions used to develop BMDMs influenced CD39 expression and observed that CD39 levels were significantly higher on L929 and M-CSF differentiated BMDMs compared to GM-CSF-induced BMDMs ( Figure 1G ). . Human monocytes and macrophages also expressed high levels of CD39 ( Figure 1H ). To address whether CD39 was directly responsible for regulating levels of macrophage- Figure 1I ). These data suggest that TLRstimulated wild-type macrophages, secrete ATP but rapidly hydrolyze it, therefore preventing eATP detection. Furthermore, similar to CD39 lo RAW264.7 cells, ATP secretion by Cd39 -/-macrophages was critically dependent on pannexin-1 ( Figure   1J ). Taken together, these data demonstrate that TLR stimulation induces intrinsic ATP release from macrophages via pannexin-1 channels, and under normal conditions macrophages utilize CD39 to control eATP bioavailability.
Extracellular ATP is rapidly hydrolyzed by macrophage ecto-enzymes.
Having demonstrated that CD39 is important for regulating the levels of macrophagederived eATP, we next characterized the CD39-specific e-NTPDase activity in macrophages. ATP hydrolysis yields the production of adenine metabolites and inorganic phosphates (P i ), therefore we first examined levels of P i released over time by RAW264.7 cells and BMDMs in the presence of eATP. Consistent with the CD39 expression data, CD39 lo RAW264.7 cells exhibited substantially impaired eATP hydrolysis compared to CD39 +/+ BMDMs ( Figure 2A ). eATP hydrolysis by macrophages was also dependent on CD39, as treatment with the CD39 inhibitor POM-1 37 as well as CD39-deficient macrophages exhibited, substantially impaired ATP hydrolysis ( Figures 2B and 2C ). The defects in purine nucleotide hydrolysis were specific to ATP and ADP, but not AMP ( Figure 1 1 2D) 13 . We next investigated whether genetic ablation of Cd39 could be rescued by the presence of apyrase, a soluble e-NTPDase
38
. Indeed, apyrase fully complemented the loss of endogenous CD39, achieving hydrolysis rates similar to Cd39 +/+ macrophages ( Figure 2D ). The low level of ATP hydrolysis by CD39-deficient macrophages may be due to the presence of low affinity non-specific phosphatases. To address this, we compared hydrolysis over time from macrophages exposed to lower levels of ATP and demonstrate that wild-type macrophages completely hydrolyze 5μM ATP within 15 minutes, compared to 30% of 500μM ATP hydrolyzed within the same time ( Figure 2E ). Importantly, macrophages lacking CD39 exhibited substantially reduced hydrolysis rates regardless of the amount of eATP present.
To further elucidate the CD39-specific e-NTPDase activity in macrophages, we utilized 31 P NMR spectroscopy, which enables the identification of each phosphorus-containing intermediate metabolite generated via eATP hydrolysis. NMR revealed that ATP remained intact and stable in macrophage-free culture medium for several hours (data not shown); however, eATP stability was drastically reduced in the presence of CD39 +/+ macrophages as evidenced by the generation of ADP and AMP from ATP. By 4 hours, ATP was completely hydrolyzed ( Figure 2F ). In contrast, a substantial fraction of ATP remained intact, even after 8 hours of exposure to Cd39 -/-macrophages ( Figure   2G ). While some ATP/ADP was hydrolyzed by CD39-deficient macrophages, which is likely due to the compensatory non-specific phosphatases, the rate of conversion of eATP to ADP and then AMP was dramatically reduced.
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From Collectively, these data suggest that CD39 is the major, high-affinity ectoATPase utilized by macrophages to hydrolyze eATP.
ATP exposure promotes regulatory macrophage development following TLR
stimulation. Although the inflammatory effect of millimolar levels of eATP is well- To further implicate macrophage-generated adenosine as a key immunomodulatory mediator, we assessed cytokine production by macrophages stimulated in the presence of adenosine deaminase (ADA), which rapidly converts adenosine into inosine thereby effectively removing adenosine from the culture. The addition of ADA to macrophages prevented the ability of adenosine or ATP to inhibit LPS-induced TNFα ( Figure 4D ) and IL-12/23p40 production 1 5
( Figure 4E ). ADA also blocked adenosine and ATP-enhancement of IL-10 production ( Figure 4F ). Thus, induction of the regulatory macrophage phenotype by eATP requires macrophage hydrolysis of ATP to adenosine.
ATP-derived adenosine attenuates inflammatory cytokine production via A2bR
signaling. There are four known receptors for adenosine: A1R, A2aR, A2bR, and A3R. qRT-PCR indicated that macrophages express low levels of transcripts for all four adenosine receptors ( Figure 5A ), and analysis of their expression over time revealed that adenosine receptor expression was dynamically regulated during macrophage activation ( Figure 5B ). Naïve macrophages express A2aR most highly ( Figure 5A ), whereas the A2bR increased in response to LPS.
Transcript levels of the other adenosine receptors declined over time (Figures 5A and 5B). These data suggest that TLR stimulation selectively upregulates A2bR expression to increase the sensitivity of the macrophage to available adenosine within the extracellular milieu.
To further study the role of the A2bR in mediating regulatory macrophage development, we examined A2br -/-macrophages following stimulation with LPS and ATP. A2br -/-macrophages expressed significantly more inflammatory transcripts compared to wild-type macrophages ( Figure 5C ), and LPS-stimulated
A2br
-/-macrophages were functionally more inflammatory than their wild-type counterparts, secreting higher amounts of TNFα and IL-12/23p40 ( Figure 5D ).
These data indicate that the A2bR was involved in the modulation of inflammatory cytokines. The A2bR was not essential for the regulation of IL-10 as Blocking ATP hydrolysis with POM-1 augmented LPS-mediated inflammatory cytokine expression, while significantly decreasing the production of Il-10 ( Figure   6A -C). We also evaluated the kinetics of cytokine production by macrophages stimulated with LPS in the presence of POM-1, and found they secreted significantly more TNFα and IL-12/23p40 and less IL-10 over time compared to macrophages activated in the absence of POM-1 (Figures 6D-F) . It is important to highlight that these data were observed in the absence of exogenous ATP, thus revealing that CD39 blockade results in the failure to convert macrophage-
We next examined whether CD39 activity could also influence the duration of inflammatory macrophage activation. To do this, macrophages were briefly stimulated with LPS in the presence or absence of POM-1. The LPS was then removed and the macrophages were re-cultured in fresh LPS-free media and cytokine release was measured over time. In the absence of POM-1, LPSstimulated macrophages decreased TNFα and IL-12/23p40 production shortly after the removal of LPS ( Figures 6G and 6H ). In contrast, POM-1 treatment resulted in the continued production of TNFα and IL-12/23p40, despite the removal of LPS from macrophage cultures ( Figures 6G and 6H ). IL-10 secretion was not similarly affected, suggesting that LPS-induced IL-10 transcripts are inherently unstable ( Figure 6I ).
CD39-deficient macrophages exhibit impaired regulatory macrophage induction.
The function of macrophage-CD39 during inflammatory diseases remains poorly understood. Therefore, inflammatory responses by Cd39 -/-macrophages were compared to wild-type macrophages. Similar to POM-1-treated macrophages, CD39-deficient macrophages produced significantly more TNFα and IL-12/23p40
and less IL-10 than their wild-type counterparts when exposed to LPS in vitro ( Figure 7A ). To investigate the role of macrophage-specific expression of CD39 in orchestrating a pro-inflammatory response in vivo, we adoptively transferred naïve Cd39 -/-macrophages into the peritoneum of wild-type mice. These mice 1 8
were then challenged with low levels of LPS and their survival was monitored over the next 5 days. 75% of mice that received Cd39 +/+ macrophages survived, whereas only 25% of the mice that received Cd39 -/-macrophages survived the endotoxin challenge ( Figure 7B ). Regulatory macrophage-specific biomarkers were also assessed in peritoneal cells from wild-type mice following adoptive transfer of either wild-type or CD39 -/-macrophages after endotoxin challenge.
Consistent with the results generated in vitro ( Figure 6A-C For personal use only. on July 15, 2017. by guest www.bloodjournal.org From
Discussion
In response to infection macrophages produce inflammatory mediators that, if not appropriately regulated, have the potential to harm the host. This is often manifested during sepsis 3, 5, 46 , where a switch from inflammatory to immunosuppressive macrophages has been suggested to play a critical role in protecting the host from lethal septic shock 4, 7, 8 . However, the molecular mechanisms governing this transition remain poorly understood. In this study, we investigated the potential for macrophages to self-regulate their activation state during inflammation. We demonstrate that the induction of inflammatory macrophage responses is accompanied by intrinsic purinergic regulatory mechanisms to limit the development of a hyper-inflammatory activation state. Although it has been well documented that macrophages exposed to exogenous adenosine exhibit immunomodulatory responses 45, 47 , the present work expands this idea and demonstrates: 1) that TLR-activated macrophages, themselves represent an important source of eATP, 2) that macrophages rapidly and efficiently convert eATP to adenosine, 3) that this conversion is dependent on CD39, and 4) that macrophages respond to eATP-derived adenosine by assuming a transcriptional profile that is characteristic of regulatory macrophages. Our data are consistent with previous reports suggesting a role for . We previously demonstrated that stimulating macrophages in the presence of cAMP led to the development of the regulatory phenotype 25 and the activation of GPCRs resulted in ERK-dependent IL-10 hyper-induction 52, 53 . Indeed, LPS-stimulated macrophages exposed to adenosine resulted in ERK activation (data not shown), thereby supporting a role for ERK in driving adenosine-induced regulatory macrophage development.
Importantly, in addition to IL-10, macrophages exposed to ATP upregulate a number of transcripts that are preferentially upregulated in regulatory macrophages compared to classically (M1) including IL-33, Sphk, and HB-EGF [23] [24] [25] [26] . Some of these regulatory macrophage-specific transcripts have been associated with lung inflammation, however their expression is likely to be tissuedependent. Indeed, the negative correlation between LPS toxicity and expression of these regulatory macrophage biomarkers in mice strongly suggests that these molecules promote immunosuppression (Figure 7) . Although Arg1 was upregulated in response to ATP, Arg1 may not be a reliable AAM-specific biomarker, because it can be induced through IL-4/IL-13-independent mechanisms. Arg1 expression via STAT3-dependent 54 and cAMP-mediated pathways 55, 56 have been previously reported. Furthermore, although it was recently reported that adenosine augments IL-4-induced alternative activation in macrophages 57 , we did not observe enhanced expression of any AAM-specific
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From biomarkers in TLR-activated macrophages exposed to ATP. Together, these observations indicate that TLR-activated macrophages exposed to eATP represent a state of activation distinct from AAMs.
Homeostatic concentrations of eATP within tissues have been estimated to be within the nM-uM range 58, 59 ; however these values likely underestimate the level of eATP within local, pericullular environment. Furthermore, eATP levels have been shown to increase 10-100-fold during pathophysiological states 59, 60 .
Therefore, it will be interesting to understand the molecular control of ATP release from macrophages. We did not observe any change in pannexin-1 Institute of Standards and Technology, nor does it imply that the material or equipment identified is necessarily the best available for the purpose.
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